RDIF, CDC IC may invest $15 mln in Russian business of Olmix

Prime, 24.05.2018

ST. PETERSBURG, May 24 (PRIME) -- The Russian Direct Investment Fund (RDIF) and CDC International Capital (CDC IC) have signed an agreement to invest up to U.S. $15 million in the Russian business of French biotechnology company Olmix, the RDIF said in a statement on Thursday.

Olmix will use the investment to expand production capacities of its facilities in St. Petersburg and to improve its presence on markets of Russia and CIS states, the statement read.